Catalyst Wire Dossier Catalyst Wire Dossier

Empagliflozin

empagliflozin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

268 regulatory and trial events tracked for Empagliflozin, covering 2014-06-13 to 2026-07-13. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes [Phase 2]

See pricing